annual D&A:
$96.43M-$7.96M(-7.63%)Summary
- As of today (September 9, 2025), BMRN annual depreciation & amortization is $96.43 million, with the most recent change of -$7.96 million (-7.63%) on December 31, 2024.
- During the last 3 years, BMRN annual D&A has fallen by -$11.61 million (-10.75%).
- BMRN annual D&A is now -10.75% below its all-time high of $108.04 million, reached on December 31, 2021.
Performance
BMRN Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$18.56M-$3.51M(-15.89%)Summary
- As of today (September 9, 2025), BMRN quarterly depreciation & amortization is $18.56 million, with the most recent change of -$3.51 million (-15.89%) on June 30, 2025.
- Over the past year, BMRN quarterly D&A has dropped by -$7.90 million (-29.85%).
- BMRN quarterly D&A is now -39.61% below its all-time high of $30.74 million, reached on September 30, 2019.
Performance
BMRN quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$83.25M-$7.90M(-8.67%)Summary
- As of today (September 9, 2025), BMRN TTM depreciation & amortization is $83.25 million, with the most recent change of -$7.90 million (-8.67%) on June 30, 2025.
- Over the past year, BMRN TTM D&A has dropped by -$23.11 million (-21.73%).
- BMRN TTM D&A is now -23.92% below its all-time high of $109.41 million, reached on September 30, 2021.
Performance
BMRN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BMRN Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -7.6% | -29.9% | -21.7% |
3 y3 years | -10.8% | -26.5% | -21.1% |
5 y5 years | -8.4% | -26.4% | -22.7% |
BMRN Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -10.8% | at low | -32.1% | at low | -21.7% | at low |
5 y | 5-year | -10.8% | at low | -33.7% | at low | -23.9% | at low |
alltime | all time | -10.8% | >+9999.0% | -39.6% | +4318.7% | -23.9% | >+9999.0% |
BMRN Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $18.56M(-15.9%) | $83.25M(-8.7%) |
Mar 2025 | - | $22.07M(-6.5%) | $91.14M(-5.5%) |
Dec 2024 | $96.43M(-7.6%) | $23.61M(+24.2%) | $96.43M(-3.3%) |
Sep 2024 | - | $19.01M(-28.2%) | $99.68M(-6.3%) |
Jun 2024 | - | $26.46M(-3.2%) | $106.36M(+1.0%) |
Mar 2024 | - | $27.35M(+1.8%) | $105.31M(+0.9%) |
Dec 2023 | $104.39M(+2.4%) | $26.86M(+4.6%) | $104.39M(+2.3%) |
Sep 2023 | - | $25.68M(+1.0%) | $102.08M(+0.9%) |
Jun 2023 | - | $25.42M(-3.8%) | $101.19M(+0.1%) |
Mar 2023 | - | $26.42M(+7.6%) | $101.05M(-0.9%) |
Dec 2022 | $101.97M(-5.6%) | $24.55M(-1.0%) | $101.97M(-1.4%) |
Sep 2022 | - | $24.80M(-1.9%) | $103.40M(-1.9%) |
Jun 2022 | - | $25.27M(-7.6%) | $105.44M(-1.8%) |
Mar 2022 | - | $27.34M(+5.2%) | $107.40M(-0.6%) |
Dec 2021 | $108.04M(+2.7%) | $25.99M(-3.2%) | $108.04M(-1.3%) |
Sep 2021 | - | $26.84M(-1.4%) | $109.41M(+0.2%) |
Jun 2021 | - | $27.23M(-2.7%) | $109.21M(+1.9%) |
Mar 2021 | - | $27.98M(+2.3%) | $107.19M(+1.9%) |
Dec 2020 | $105.17M(-0.1%) | $27.36M(+2.7%) | $105.17M(+1.5%) |
Sep 2020 | - | $26.63M(+5.6%) | $103.60M(-3.8%) |
Jun 2020 | - | $25.22M(-2.9%) | $107.71M(-1.0%) |
Mar 2020 | - | $25.96M(+0.7%) | $108.84M(+3.4%) |
Dec 2019 | $105.30M(+10.1%) | $25.79M(-16.1%) | $105.30M(+1.0%) |
Sep 2019 | - | $30.74M(+16.7%) | $104.23M(+4.4%) |
Jun 2019 | - | $26.34M(+17.5%) | $99.83M(+5.7%) |
Mar 2019 | - | $22.43M(-9.3%) | $94.47M(-1.3%) |
Dec 2018 | $95.67M(+8.9%) | $24.72M(-6.2%) | $95.67M(-4.0%) |
Sep 2018 | - | $26.34M(+25.6%) | $99.62M(+6.0%) |
Jun 2018 | - | $20.98M(-11.2%) | $93.97M(+2.1%) |
Mar 2018 | - | $23.63M(-17.6%) | $92.08M(+4.8%) |
Dec 2017 | $87.86M(-9.3%) | $28.66M(+38.5%) | $87.86M(+10.8%) |
Sep 2017 | - | $20.70M(+8.5%) | $79.30M(-9.9%) |
Jun 2017 | - | $19.09M(-1.7%) | $88.03M(-9.8%) |
Mar 2017 | - | $19.41M(-3.5%) | $97.60M(+0.7%) |
Dec 2016 | $96.91M(+105.4%) | $20.11M(-31.7%) | $96.91M(+23.2%) |
Sep 2016 | - | $29.42M(+2.7%) | $78.69M(+21.1%) |
Jun 2016 | - | $28.66M(+53.0%) | $64.99M(+26.2%) |
Mar 2016 | - | $18.73M(+895.5%) | $51.52M(+9.2%) |
Dec 2015 | $47.19M(-16.8%) | $1.88M(-88.0%) | $47.19M(-24.0%) |
Sep 2015 | - | $15.73M(+3.6%) | $62.13M(+2.5%) |
Jun 2015 | - | $15.18M(+5.5%) | $60.62M(+2.5%) |
Mar 2015 | - | $14.40M(-14.4%) | $59.12M(+4.2%) |
Dec 2014 | $56.74M(+20.1%) | $16.82M(+18.3%) | $56.74M(+15.1%) |
Sep 2014 | - | $14.22M(+4.0%) | $49.30M(+1.7%) |
Jun 2014 | - | $13.68M(+13.8%) | $48.46M(+1.5%) |
Mar 2014 | - | $12.02M(+28.1%) | $47.72M(+1.0%) |
Dec 2013 | $47.26M(+4.3%) | $9.38M(-29.8%) | $47.26M(-5.0%) |
Sep 2013 | - | $13.38M(+3.4%) | $49.74M(+3.6%) |
Jun 2013 | - | $12.94M(+11.9%) | $48.03M(+3.8%) |
Mar 2013 | - | $11.56M(-2.5%) | $46.26M(+2.1%) |
Dec 2012 | $45.30M(+25.5%) | $11.86M(+1.6%) | $45.30M(+5.2%) |
Sep 2012 | - | $11.67M(+4.4%) | $43.07M(+5.7%) |
Jun 2012 | - | $11.17M(+5.4%) | $40.75M(+6.9%) |
Mar 2012 | - | $10.60M(+10.1%) | $38.11M(+5.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $36.09M(+30.1%) | $9.63M(+3.0%) | $36.09M(+4.9%) |
Sep 2011 | - | $9.35M(+9.6%) | $34.40M(+4.7%) |
Jun 2011 | - | $8.53M(-0.6%) | $32.87M(+6.3%) |
Mar 2011 | - | $8.59M(+8.2%) | $30.91M(+11.4%) |
Dec 2010 | $27.74M(+32.2%) | $7.93M(+1.4%) | $27.74M(+12.4%) |
Sep 2010 | - | $7.82M(+18.9%) | $24.67M(+13.7%) |
Jun 2010 | - | $6.58M(+21.6%) | $21.69M(+1.9%) |
Mar 2010 | - | $5.41M(+11.3%) | $21.28M(+1.5%) |
Dec 2009 | $20.98M(+19.0%) | $4.86M(+0.4%) | $20.98M(+0.5%) |
Sep 2009 | - | $4.84M(-21.5%) | $20.87M(+1.4%) |
Jun 2009 | - | $6.17M(+20.9%) | $20.58M(+9.1%) |
Mar 2009 | - | $5.10M(+7.3%) | $18.86M(+7.0%) |
Dec 2008 | $17.63M(+30.2%) | $4.76M(+4.5%) | $17.63M(+6.3%) |
Sep 2008 | - | $4.55M(+2.3%) | $16.58M(+6.9%) |
Jun 2008 | - | $4.45M(+15.0%) | $15.51M(+7.9%) |
Mar 2008 | - | $3.87M(+4.5%) | $14.38M(+6.2%) |
Dec 2007 | $13.54M(+13.3%) | $3.71M(+6.2%) | $13.54M(+9.2%) |
Sep 2007 | - | $3.49M(+5.3%) | $12.40M(+3.4%) |
Jun 2007 | - | $3.31M(+9.1%) | $12.00M(-3.7%) |
Mar 2007 | - | $3.04M(+18.5%) | $12.46M(+4.2%) |
Dec 2006 | $11.96M(+18.7%) | $2.56M(-17.0%) | $11.96M(-1.8%) |
Sep 2006 | - | $3.09M(-18.3%) | $12.17M(+5.7%) |
Jun 2006 | - | $3.78M(+49.0%) | $11.52M(+13.5%) |
Mar 2006 | - | $2.54M(-8.6%) | $10.14M(+0.7%) |
Dec 2005 | $10.07M(-24.1%) | $2.77M(+14.2%) | $10.07M(+27.5%) |
Sep 2005 | - | $2.43M(+1.0%) | $7.90M(-32.4%) |
Jun 2005 | - | $2.40M(-2.5%) | $11.68M(-13.5%) |
Mar 2005 | - | $2.47M(+311.7%) | $13.49M(+1.6%) |
Dec 2004 | $13.28M(+40.6%) | $599.00K(-90.4%) | $13.28M(-11.9%) |
Sep 2004 | - | $6.21M(+47.1%) | $15.06M(+27.8%) |
Jun 2004 | - | $4.22M(+87.5%) | $11.79M(+22.7%) |
Mar 2004 | - | $2.25M(-5.6%) | $9.61M(+1.8%) |
Dec 2003 | $9.44M(+11.0%) | $2.38M(-18.7%) | $9.44M(-0.6%) |
Sep 2003 | - | $2.93M(+43.7%) | $9.50M(+7.9%) |
Jun 2003 | - | $2.04M(-2.2%) | $8.81M(+0.8%) |
Mar 2003 | - | $2.08M(-14.7%) | $8.74M(+2.7%) |
Dec 2002 | $8.50M(+37.8%) | $2.44M(+9.2%) | $8.50M(+1.2%) |
Sep 2002 | - | $2.24M(+13.7%) | $8.40M(+11.3%) |
Jun 2002 | - | $1.97M(+6.3%) | $7.55M(+10.0%) |
Mar 2002 | - | $1.85M(-21.1%) | $6.86M(+11.2%) |
Dec 2001 | $6.17M(+3.8%) | $2.35M(+69.6%) | $6.17M(+13.9%) |
Sep 2001 | - | $1.38M(+7.9%) | $5.42M(-3.2%) |
Jun 2001 | - | $1.28M(+10.3%) | $5.60M(-0.8%) |
Mar 2001 | - | $1.16M(-27.1%) | $5.64M(-5.1%) |
Dec 2000 | $5.95M(+14.0%) | $1.59M(+2.2%) | $5.95M(-6.7%) |
Sep 2000 | - | $1.56M(+17.6%) | $6.38M(-0.8%) |
Jun 2000 | - | $1.33M(-9.5%) | $6.43M(+2.6%) |
Mar 2000 | - | $1.47M(-27.5%) | $6.26M(+20.0%) |
Dec 1999 | $5.22M(+801.2%) | $2.02M(+25.5%) | $5.22M(+63.3%) |
Sep 1999 | - | $1.61M(+38.7%) | $3.19M(+101.9%) |
Jun 1999 | - | $1.16M(+176.6%) | $1.58M(+276.6%) |
Mar 1999 | - | $420.10K | $420.10K |
Dec 1998 | $578.90K(>+9900.0%) | - | - |
Dec 1997 | $4800.00 | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual depreciation & amortization?
- What is the all time high annual D&A for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual D&A year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly D&A year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM D&A year-on-year change?
What is BioMarin Pharmaceutical Inc. annual depreciation & amortization?
The current annual D&A of BMRN is $96.43M
What is the all time high annual D&A for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual depreciation & amortization is $108.04M
What is BioMarin Pharmaceutical Inc. annual D&A year-on-year change?
Over the past year, BMRN annual depreciation & amortization has changed by -$7.96M (-7.63%)
What is BioMarin Pharmaceutical Inc. quarterly depreciation & amortization?
The current quarterly D&A of BMRN is $18.56M
What is the all time high quarterly D&A for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly depreciation & amortization is $30.74M
What is BioMarin Pharmaceutical Inc. quarterly D&A year-on-year change?
Over the past year, BMRN quarterly depreciation & amortization has changed by -$7.90M (-29.85%)
What is BioMarin Pharmaceutical Inc. TTM depreciation & amortization?
The current TTM D&A of BMRN is $83.25M
What is the all time high TTM D&A for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM depreciation & amortization is $109.41M
What is BioMarin Pharmaceutical Inc. TTM D&A year-on-year change?
Over the past year, BMRN TTM depreciation & amortization has changed by -$23.11M (-21.73%)